Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Mangalam Drugs & Organics Statistics

Total Valuation

NSE:MANGALAM has a market cap or net worth of INR 474.69 million. The enterprise value is 1.59 billion.

Market Cap	474.69M
Enterprise Value	1.59B

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	15.83M
Shares Outstanding	n/a
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	26.31%
Owned by Institutions (%)	n/a
Float	8.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.20
PB Ratio	0.46
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	11.36
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.59
EV / Sales	0.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.65

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.09.

Current Ratio	0.79
Quick Ratio	0.21
Debt / Equity	1.09
Debt / EBITDA	n/a
Debt / FCF	-14.60
Interest Coverage	-2.00

Financial Efficiency

Return on equity (ROE) is -35.23% and return on invested capital (ROIC) is -14.69%.

Return on Equity (ROE)	-35.23%
Return on Assets (ROA)	-5.94%
Return on Invested Capital (ROIC)	-14.69%
Return on Capital Employed (ROCE)	-27.34%
Weighted Average Cost of Capital (WACC)	9.44%
Revenue Per Employee	4.85M
Profits Per Employee	-925,000
Employee Count	480
Asset Turnover	0.68
Inventory Turnover	1.30

Taxes

Income Tax	-41.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.66% in the last 52 weeks. The beta is 0.12, so NSE:MANGALAM's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-62.66%
50-Day Moving Average	30.04
200-Day Moving Average	47.51
Relative Strength Index (RSI)	46.01
Average Volume (20 Days)	19,307

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MANGALAM had revenue of INR 2.33 billion and -444.00 million in losses. Loss per share was -28.05.

Revenue	2.33B
Gross Profit	760.20M
Operating Income	-323.63M
Pretax Income	-485.71M
Net Income	-444.00M
EBITDA	-141.40M
EBIT	-323.63M
Loss Per Share	-28.05

Balance Sheet

The company has 7.51 million in cash and 1.13 billion in debt, with a net cash position of -1.12 billion.

Cash & Cash Equivalents	7.51M
Total Debt	1.13B
Net Cash	-1.12B
Net Cash Per Share	n/a
Equity (Book Value)	1.03B
Book Value Per Share	65.12
Working Capital	-408.69M

Cash Flow

In the last 12 months, operating cash flow was 41.78 million and capital expenditures -118.99 million, giving a free cash flow of -77.22 million.

Operating Cash Flow	41.78M
Capital Expenditures	-118.99M
Depreciation & Amortization	182.23M
Net Borrowing	218.68M
Free Cash Flow	-77.22M
FCF Per Share	n/a

Margins

Gross margin is 32.64%, with operating and profit margins of -13.90% and -19.06%.

Gross Margin	32.64%
Operating Margin	-13.90%
Pretax Margin	-20.86%
Profit Margin	-19.06%
EBITDA Margin	-6.07%
EBIT Margin	-13.90%
FCF Margin	n/a

Dividends & Yields

NSE:MANGALAM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-93.53%
FCF Yield	-16.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3